Abstract
The review summarizes the outcomes of several landmark trials involving aromatase inhibitors that helped formulate current therapeutic approaches recommended by the American Society of Clinical Oncology for breast carcinoma treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 975-981 |
| Number of pages | 7 |
| Journal | cancer |
| Volume | 106 |
| Issue number | 5 |
| DOIs | |
| State | Published - Mar 1 2006 |
Keywords
- Aromatase inhibitors
- Breast carcinoma
- Clinical trials
- Endocrine adjuvant therapy
- Tamoxifen
ASJC Scopus subject areas
- Oncology
- Cancer Research
